BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dellon ES, Gupta SK. A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2019;17:2149-2160. [PMID: 30710696 DOI: 10.1016/j.cgh.2019.01.030] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Chen J, Oshima T, Huang X, Tomita T, Fukui H, Miwa H. Esophageal Mucosal Permeability as a Surrogate Measure of Cure in Eosinophilic Esophagitis. JCM 2022;11:4246. [DOI: 10.3390/jcm11144246] [Reference Citation Analysis]
2 Yalon M, Tahboub Amawi AD, Kelm ZS, Wells ML, Teo LLS, Heiken JP, Sheedy SP, Torbenson MS, Fidler JL, Venkatesh SK. Eosinophilic Disorders of the Gastrointestinal Tract and Associated Abdominal Viscera: Imaging Findings and Diagnosis. Radiographics 2022;42:1081-102. [PMID: 35749291 DOI: 10.1148/rg.220004] [Reference Citation Analysis]
3 Facchin S, Calgaro M, Pandolfo M, Caldart F, Ghisa M, Greco E, Sattin E, Valle G, Dellon E, Vitulo N, Savarino EV. Salivary microbiota composition may discriminate between patients with eosinophilic oesophagitis (EoE) and non-EoE subjects. Aliment Pharmacol Ther 2022. [PMID: 35715947 DOI: 10.1111/apt.17091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-Katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, McGowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves SS. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Gastroenterology 2022:S0016-5085(22)00287-6. [PMID: 35606197 DOI: 10.1053/j.gastro.2022.03.025] [Reference Citation Analysis]
5 Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, Mcgowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves SS. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Journal of Allergy and Clinical Immunology 2022. [DOI: 10.1016/j.jaci.2022.03.015] [Reference Citation Analysis]
6 Miehlke S, Schlag C, Lucendo AJ, Biedermann L, Vaquero CS, Schmoecker C, Hayat J, Hruz P, Ciriza de Los Rios C, Bredenoord AJ, Vieth M, Schoepfer A, Attwood S, Mueller R, Burrack S, Greinwald R, Straumann A; International EOS-2 Study Group. Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme. United European Gastroenterol J 2022;10:330-43. [PMID: 35412032 DOI: 10.1002/ueg2.12220] [Reference Citation Analysis]
7 Thakkar KP, Fowler M, Keene S, Iuga A, Dellon ES. Long-term efficacy of proton pump inhibitors as a treatment modality for eosinophilic esophagitis. Dig Liver Dis 2022:S1590-8658(22)00209-2. [PMID: 35410852 DOI: 10.1016/j.dld.2022.03.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Tamarit-sebastian S, Ferrer-soler FM, Lucendo AJ. Current options and investigational drugs for the treatment of eosinophilic esophagitis. Expert Opinion on Investigational Drugs. [DOI: 10.1080/13543784.2022.2033207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ma C, Jairath V, Feagan BG, Guizzetti L, Zou G, McFarlane SC, Shackelton LM, Collins MH, Hirano I, de Rooij WE, Schaeffer DF, Pai RK, Bredenoord AJ, Dellon ES. Responsiveness of a Histologic Scoring System Compared With Peak Eosinophil Count in Eosinophilic Esophagitis. Am J Gastroenterol 2021. [PMID: 34797816 DOI: 10.14309/ajg.0000000000001571] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Ketchem CJ, Thakkar KP, Xue A, Reddy S, Abramson L, Greenberg SB, Abichandani S, Miller TL, Chang NC, Eluri S, Reed CC, Dellon ES. Older patients with eosinophilic esophagitis have high treatment response to topical steroids. Dig Liver Dis 2021:S1590-8658(21)00809-4. [PMID: 34789398 DOI: 10.1016/j.dld.2021.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Chang NC, Thakkar KP, Ketchem CJ, Eluri S, Reed CC, Dellon ES. A Gap in Care Leads to Progression of Fibrosis in Eosinophilic Esophagitis Patients. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01141-1. [PMID: 34718172 DOI: 10.1016/j.cgh.2021.10.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
12 Dellon ES, Woosley JT, McGee SJ, Moist SE, Shaheen NJ. Utility of major basic protein, eotaxin-3, and mast cell tryptase staining for prediction of response to topical steroid treatment in eosinophilic esophagitis: analysis of a randomized, double-blind, double dummy clinical trial. Dis Esophagus 2020;33:doaa003. [PMID: 32193541 DOI: 10.1093/dote/doaa003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Rokkas T, Niv Y, Malfertheiner P. A Network Meta-Analysis of Randomized Controlled Trials on the Treatment of Eosinophilic Esophagitis in Adults and Children. J Clin Gastroenterol 2021;55:400-10. [PMID: 32398629 DOI: 10.1097/MCG.0000000000001356] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Miehlke S, von Arnim U, Schlag C, Labenz J, Madisch A. [Treatment of eosinophilic esophagitis - advancements and perspectives]. Z Gastroenterol 2021;59:869-78. [PMID: 34157757 DOI: 10.1055/a-1429-4192] [Reference Citation Analysis]
15 Visaggi P, Mariani L, Pardi V, Rosi EM, Pugno C, Bellini M, Zingone F, Ghisa M, Marabotto E, Giannini EG, Savarino V, Marchi S, Savarino EV, de Bortoli N. Dietary Management of Eosinophilic Esophagitis: Tailoring the Approach. Nutrients 2021;13:1630. [PMID: 34066243 DOI: 10.3390/nu13051630] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
16 Wechsler JB, Schwartz S, Arva NC, Kim KA, Chen L, Makhija M, Amsden K, Keeley K, Mohammed S, Dellon ES, Kagalwalla AF. A Single Food Milk Elimination Diet Is Effective for Treatment of Eosinophilic Esophagitis in Children. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00384-0. [PMID: 33823291 DOI: 10.1016/j.cgh.2021.03.049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
17 Safroneeva E, Cotton CC, Schoepfer AM, Zwahlen M, Woosley JT, Dellon ES. Dilation Modifies Association Between Symptoms and Esophageal Eosinophilia in Adult Patients With Eosinophilic Esophagitis. Am J Gastroenterol 2020;115:2098-102. [PMID: 33009060 DOI: 10.14309/ajg.0000000000000957] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
18 Chang JW, Haller E, Dellon ES. Dietary Management of Eosinophilic Esophagitis: Man Versus Food or Food Versus Man? Gastroenterol Clin North Am 2021;50:59-75. [PMID: 33518169 DOI: 10.1016/j.gtc.2020.10.009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Dellon ES. Red Between the Lines: Evolution of Eosinophilic Esophagitis as a Distinct Clinicopathologic Syndrome. Dig Dis Sci 2020;65:3434-47. [PMID: 33052498 DOI: 10.1007/s10620-020-06642-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Nennstiel S, Schlag C. Treatment of eosinophlic esophagitis with swallowed topical corticosteroids. World J Gastroenterol 2020; 26(36): 5395-5407 [PMID: 33024392 DOI: 10.3748/wjg.v26.i36.5395] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Greuter T, Godat A, Ringel A, Almonte HS, Schupack D, Mendoza G, McCright-Gill T, Dellon ES, Hirano I, Alexander J, Chehade M, Safroneeva E, Bussmann C, Biedermann L, Schreiner P, Schoepfer AM, Straumann A, Katzka DA. Effectiveness and Safety of High- vs Low-Dose Swallowed Topical Steroids for Maintenance Treatment of Eosinophilic Esophagitis: A Multicenter Observational Study. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31136-8. [PMID: 32798703 DOI: 10.1016/j.cgh.2020.08.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
22 Fernandez-Becker NQ, Raja S, Scarpignato C, Lynch KL, Ahuja NK, Horsley-Silva JL. Eosinophilic esophagitis: updates on key unanswered questions. Ann N Y Acad Sci 2020;1481:30-42. [PMID: 32762154 DOI: 10.1111/nyas.14421] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Reddy A, Ashat D, Murali AR. Recent insights on the use of topical steroids in eosinophilic esophagitis. Expert Rev Gastroenterol Hepatol 2020;14:953-63. [PMID: 32567417 DOI: 10.1080/17474124.2020.1785869] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Lingblom C, Albinsson S, Johansson L, Larsson H, Wennerås C. Patient-Reported Outcomes and Blood-Based Parameters Identify Response to Treatment in Eosinophilic Esophagitis. Dig Dis Sci 2021;66:1556-64. [PMID: 32495256 DOI: 10.1007/s10620-020-06368-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Ananthakrishnan A. Issue Highlights. Clinical Gastroenterology and Hepatology 2020;18:1405-8. [DOI: 10.1016/j.cgh.2020.04.021] [Reference Citation Analysis]
26 Lucendo AJ. Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies. Expert Rev Clin Immunol 2020;16:63-77. [PMID: 31842634 DOI: 10.1080/1744666X.2019.1705784] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Hirano I, Furuta GT. Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis. Gastroenterology 2020;158:840-51. [PMID: 31836530 DOI: 10.1053/j.gastro.2019.09.052] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
28 Atwal K, Hubbard GP, Venter C, Stratton RJ. The use of amino acid-based nutritional feeds is effective in the dietary management of pediatric eosinophilic oesophagitis. Immun Inflamm Dis 2019;7:292-303. [PMID: 31692292 DOI: 10.1002/iid3.273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 Oliva S, Laudadio I, Fulci V, Rossetti D, Isoldi S, Stronati L, Carissimi C. SERPINB12 as a possible marker of steroid dependency in children with eosinophilic esophagitis: A pilot study. Dig Liver Dis 2020;52:158-63. [PMID: 31653522 DOI: 10.1016/j.dld.2019.08.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Gómez-Aldana A, Jaramillo-Santos M, Delgado A, Jaramillo C, Lúquez-Mindiola A. Eosinophilic esophagitis: Current concepts in diagnosis and treatment. World J Gastroenterol 2019; 25(32): 4598-4613 [PMID: 31528089 DOI: 10.3748/wjg.v25.i32.4598] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
31 Dellon ES. Cost-effective care in eosinophilic esophagitis. Ann Allergy Asthma Immunol 2019;123:166-72. [PMID: 31009702 DOI: 10.1016/j.anai.2019.04.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]